ReviewFrontiers in oncology2018

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi.

Amila Suraweera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.